循环RMST与血统驱动的转录因子合作,以控制神经内分泌转化差异化
Mona Teng1, Jiacheng Guo2, Xin Xu3
1Department of Medical Biophysics, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
Cancer cell
|April 18, 2025
概括
循环RNA RMST通过调节ASCL1.1驱动神经内分泌癌症. 敲除circRMST可以防止转基因分化,维持腺癌的状态并影响瘤的生长.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 循环RNA (circRNAs) 是具有调节功能的非编码RNA.
- 环RNAs在腺癌转化为神经内分泌癌症中的作用在很大程度上是未知的.
研究的目的:
- 研究circRNAs在前列腺和肺腺癌转化成神经内分泌前列腺癌 (NEPC) 和小细胞肺癌 (SCLC) 的作用.
- 确定参与该过程的特定circRNA,并阐明它们的作用机制.
主要方法:
- 在NEPC和SCLC患者样本中识别和量化circRNAs.
- 使用RNA干扰 (shRNA,siRNA) 和基因编辑 (CRISPR-Cas13,Cas9) 来评估circRMST的影响的功能研究.
- 分析蛋白质降解途径 (自-溶解体) 和转录因子结合 (NKX2-1,SOX2).
- 在小鼠的基因淘汰模型中研究Rmst.的体内效应.
主要成果:
- circRMST被确定为NEPC和SCLC中非常丰富的circRNA,在物种中保存.
- circRMST对于瘤生长和ASCL1的表达至关重要,ASCL1是神经内分泌分化的关键调节者.
- 在小鼠模型中,Rmst的遗传淘汰抑制了神经内分泌转基因差异化,从而保留了腺癌表型.
- circRMST与转录因子NKX2-1和SOX2.2进行物理相互作用.
- 失去circRMST导致NKX2-1蛋白通过自降解和改变SOX2基因组结合,导致ASCL1转录减少.
结论:
- circRMST在腺癌转化为NEPC和SCLC中发挥着关键作用.
- circRMST是神经内分泌癌症的潜在治疗点.
- 该机制涉及circRMST与NKX2-1和SOX2的相互作用,调节ASCL1表达和细胞命运.
相关概念视频
Forced Transdifferentiation
1.8K
Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial...
Artificial...
1.8K
Master Transcription Regulators
6.8K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.8K
Lineage Commitment
2.9K
Commitment is the process whereby stem cells:
2.9K
Methods of Nuclear Reprogramming
1.8K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.8K
Transcription
146.1K
Overview
Transcription is the process of synthesizing RNA from a DNA sequence by RNA polymerase. It is the first step in producing a protein from a gene sequence. Additionally, many other proteins and regulatory sequences are involved in the proper synthesis of messenger RNA (mRNA). Regulation of transcription is responsible for the differentiation of all the different types of cells and often for the proper cellular response to environmental signals.
Transcription Can Produce Different Kinds...
Transcription is the process of synthesizing RNA from a DNA sequence by RNA polymerase. It is the first step in producing a protein from a gene sequence. Additionally, many other proteins and regulatory sequences are involved in the proper synthesis of messenger RNA (mRNA). Regulation of transcription is responsible for the differentiation of all the different types of cells and often for the proper cellular response to environmental signals.
Transcription Can Produce Different Kinds...
146.1K
Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K


